aarogya.com
  • Home
  • Complementary Medicine
    • Ayurveda
    • Homeopathy
    • Naturopathy
    • Acupressure
    • Acupuncture
    • Aromatherapy
    • Batch Flower Remedies
    • Home Remedies
    • Massage
    • Yoga
    • Meditation
    • Reiki
    • Bodywork
    • Medical Palmistry
  • Conditions & Diseases
    • Acute Diarrheal Disease
    • Appendicitis
    • Blindness
    • Brucellosis
    • Chicken Pox
    • Conjunctivitis
    • Dysentery
    • Hookworm
    • Japanese Encephalitis
    • Lymphatic Filariasis
    • Plague
    • Rubella
    • Typhoid Fever
    • Yellow Fever
    • Allergy
    • Arthritis
    • Blood Pressure
    • Computer Health Hazards
    • Chikungunya Fever
    • Dengue
    • Guinea Worm
    • Influenza
    • Leprosy
    • Malaria
    • Poliomyelitis
    • Tetanus
    • Whooping Cough
    • Viral Hepatitis
    • Amebiasis
    • Asthma
    • Bronchitis
    • Diagnostic Tests
    • Cholera
    • Diphtheria
    • Hepatitis
    • Irritable Bowel Syndrome
    • Leptospirosis
    • Measles
    • Rabies
    • Tuberculosis
    • Yaws
  • Family Health
    • Children's Health
    • Diet & Nutrition
    • First Aid
    • Fitness
    • Humor & Trivia
    • Men's Health
    • Preventive Health
    • Senior's Health
    • Senior Citizen Corner
    • Teen’s Health
    • Vets and Pets
    • Women’s Health
  • Health Resources
    • Blood Donation
    • Career Opportunities
    • Daily Health Tips
    • Health Programs
    • Featured Hospitals
    • Medical Education
    • Health Professional's Negligence
    • Medical Tourism
    • Video Eye
    • Rural Health
    • Patients' Rights Forum
  • Insurance
    • Euthanasia
    • Health Insurance
    • Health Insurance Policies
    • Insurance Companies
    • Medical Ethics
    • Medical Jurisprudence
    • Research
    • Telemedicine
    • Compare Health Insurance
  • Sex & Sexuality
    • What is Sex & Sexuality?
    • FAQs
    • Marriage & Pregnancy
    • Sex Education
  • Support Groups
    • Addiction
    • Aids
    • Cancer
    • Epilepsy
    • Swine Flu
    • Blood Search
    • Vivah
    • Health Directory
    • Alzheimer's Disease
    • Medical Support Groups
    • Cardiology
    • Depression
    • Depression Screening Test
    • Diabetes
    • Disability
    • Kidney
    • Obesity
    • Pregnancy
    • Schizophrenia
    • Vitiligo
Aarogya.com
Marathi | Gujarati | Register | Login
  • Home
  • News and Updates
  • Year 2013
  • Patent War Spills Over to Non-Cancer Drugs

Patent War Spills Over to Non-Cancer Drugs

  • Print
Details
Hits: 6374

The turf war between Big Pharma and generic companies, which was largely restricted to exorbitantly priced drugs for cancer and HIV, is now spilling over to chronic and lifestyle problems. In yet another instance of a drug MNC losing monopoly, the Chennai Patent Office, an opposition filed by Ranbaxy, has revoked Pfizer’s patent on a drug used in urinary incontinence, which is expected to bring down its price substantially.

Significantly, the revocation of the patent may challenge Pfizer’s claims of monopoly on the Detrol formulation, experts say. The patent office recently revoked Pfizer claims on patent exclusivity for a formulation of its best-selling drug Detrol, used to manage overactive bladder symptoms.

The patent office said the invention claimed in the revoked patent was found to be "prior claimed" by another patent of Pfizer on the same drug. The invention claimed in the revoked patent was also found to be obvious, and not involving any technical advancement compared to existing knowledge, legal sources say. Simply put, the invention claimed in the patent is same to the formulation on which Pfizer has monopoly rights, weakening the basic premise of the first patent.

Patent War Spills Over to Non-Cancer Drugs

Pfizer had two patents on Detrol, the first patent (211539) was filed in August 1999, and the second (229260) three months later in November.

Though Pfizer’s first patent on Detrol is still valid, experts say that it is now under threat, as the second one has been revoked.

"In case the second patent (229260) on the extended release formulation of Detrol was not revoked, Pfizer would have had almost an additional three months of monopoly up to November 2019 instead of August 2019, when the first patent (211539) on the said formulation is supposed to expire. Generic companies are likely to use this additional three months time. Moreover, since the second patent has been revoked for being ‘prior claimed’, that is by the invention already claimed in the first one, it implies that the first patent is prone to attack on grounds of obviousness and lack of inventive step, and hence may be an inspiration for other players to attack the first patent," said Sanchita Ganguli, patent attorney at S Majumdar, the firm which represented Ranbaxy.

Ranbaxy declined to comment on its future strategy regarding opposing the first patent, now that the second has been revoked. Pfizer’s first patent on the drug is on weak ground and now prone to attack, experts say. Earlier, Ranbaxy had opposed the first patent on Detrol, and lost the case.

A spokesperson from Pfizer said the company is "reviewing the decision and considering its options".

Source
Times of India
19 Dec 2013,
Mumbai, India
by - Rupali Mukherjee

Disclaimer: The news story on this page is the copyright of the cited publication. This has been reproduced here for visitors to review, comment on and discuss. This is in keeping with the principle of ’Fair dealing’ or ’Fair use’. Visitors may click on the publication name, in the news story, to visit the original article as it appears on the publication’s website.

0
Introducing Digital Practice for Doctors & Healthcare professionals
Swine Flu
National Award for Outstanding achievement by a Non-Professional - Tushar Sampat
Health Professional's Negligence
Health Professional's Negligence
Records of published articles in the newspapers helps common people about precautions to be taken while seeking the services from health professionals and also helps health professionals to rectify the negligence.
read more…
Specialties
Common Symptoms


Aarogya Network

aarogya.com aims to be India’s leading comprehensive health information portal. The site has sections, which cover almost all the medical specialties and give useful information on various diseases. To enhance its reach, the content is available in Indian languages too. We were the first health website to introduce online support groups. Addiction support and Epilepsy support are examples of some very active and vibrant communities.

» Click here to see all our support groups

Subscribe to Our Newsletter

 Get health related new information.

Pune Aarogya
Digital Media Dedicated to Healthcare of Punekars

Health Tools

  • Health Directory
  • Message Board
  • Health Calculators
  • Depression Screening Test

About Aarogya.com

aarogya.com aims to be India’s leading comprehensive health information portal. The site has sections, which cover almost all the medical specialties

Read more...

Suggestions

This is YOUR site, so if you have suggestions or feedback on how we can improve it for you, please let us know! We do our best to keep up!

Read more...

User Comments

“My name is Paulette Conners and I just had to send you an email thanking you since one of the pages on your site was very helpful!”

  • About Us
  • Company Profile
  • Contact Us
  • Privacy Policy
  • Feedback
  • Disclaimer
  • Sitemap
  • Invite Your Friends

© 2017 www.aarogya.com. All Rights Reserved.